Lasix (furosemide) Tablets October 2008
Detailed View: Safety Labeling Changes Approved By FDA Center for Drug Evaluation and Research (CDER) -- October 2008
|The detailed view includes drug products with safety labeling changes to the BOXED WARNING, CONTRAINDICATIONS, WARNINGS, PRECAUTIONS, ADVERSE REACTIONS, or PATIENT PACKAGE INSERT/MEDICATION GUIDE sections. Deletions or editorial revisions made to these sections are not included in this summary. Read about the new physician labeling format.|
- Gastrointestinal System Reactions
- hepatic encephalopathy in patients with hepatocellular insufficiency (added)
- Dermatologic-Hypersensitivity Reactions
- bullous pemphigoid (added)
Label is not available on this site.